Hims & Hers Health (NYSE: HIMS) Faces Securities Fraud Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower
Hagens Berman issued a shareholder-solicitation notice for a securities fraud class action against Hims & Hers Health, naming a class period of Aug. 4, 2025 through July 29, 2026 with a lead plaintiff deadline of Nov. 2, 2026. The class action stems from a July 29, 2026 FTC complaint, joined by Utah and Los Angeles County, alleging deceptive sharing of consumer health data with ad platforms and ROSCA-violating subscription billing practices.
Key figures
- Class period end
- July 29, 2026
- Market cap erased
- $970 million
- Class period start
- Aug. 4, 2025
- Lead plaintiff deadline
- Nov. 2, 2026
- One day stock decline pct
- -14.7%
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.